Bayer Czech Republic's operating cash flow stood at CZK 122 mil in 2017, up 149% when compared to the previous year. Historically, between 2003 - 2017, the firm’s operating cash flow reached a high of CZK 479 mil in 2008 and a low of CZK -247 mil in 2016.
Bayer Czech Republic's total investments stood at CZK -3.60 mil and accounted for 0.088% of sales in 2017. This is compared to an average of 0.101% as seen over the last five years.
Cash from financing amounted to CZK -113 mil, so the company generated CZK 5.25 mil net cash in 2017.
At the end of 2017, the company had a net debt of CZK 393 mil, or 2.49x of EBITDA and 94.4% of equity. Net working capital amounted to CZK 984 mil, or 23.5% of sales. Cash conversion cycle is negative and reached 91.9 days days in 2017. This means Bayer Czech Republic generates revenue from customers before it has to pay its suppliers for inventory, among other things.
You can see all the company’s data at Bayer Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
